Creative Biolabs-Immuno-oncology

PharmaOnco™ CHO-Tg(Human SLAMF7) Stable Cell Line, Single Clone (CAT#: ITS-0822-HMM201)

DatasheetDatasheet
Short Description
Creative Biolabs offers CHO-Tg(Human SLAMF7) stable cell line which the SLAMF7 gene stably expressed in CHO cells.
Description
CHO-Tg(Human SLAMF7) stable cell line is a cell line derived from Chinese hamster ovary (CHO) cells that have been genetically modified to express the human SLAMF7 gene. SLAMF7, also known as CS1, is a cell surface glycoprotein that is expressed on natural killer cells and a subset of T cells. It plays a role in cell adhesion and signaling. CHO-Tg(Human SLAMF7) stable cell line can be used for various applications in research and drug development, such as screening for SLAMF7-targeted therapeutics, studying the role of SLAMF7 in immune cell function, and investigating the interaction between SLAMF7 and its ligands.
Features
Consistent gene expression;
Reliability and reproducibility;
Applications
Functional assay
Protein Target
SLAMF7
Species
Human
Parental Cell Line
CHO
Gene
Genbank #NM_021181
Background
SLAMF7 (Signaling Lymphocytic Activation Molecule Family member 7) is a gene that encodes a cell surface receptor protein involved in the regulation of immune responses. SLAMF7 is primarily expressed on natural killer (NK) cells, plasma cells, and a subset of T cells. It plays a role in cell adhesion, activation, and cytotoxicity in the immune system. Mutations in the SLAMF7 gene have been associated with various immune system disorders, including autoimmune diseases and immunodeficiencies. Targeting SLAMF7 with monoclonal antibodies has shown promise as a treatment for multiple myeloma, a type of blood cancer that affects plasma cells.
Related Products

For Research Use Only | Not For Clinical Use

Online Inquiry
Copyright © 2026 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.
Close
Thanksgiving
Thanksgiving